China Sky One Medical, Inc. was granted SFDA approval for two new drugs: Oxymetazoline Hydrochloride Nasal Drops and Taurine Eye Drops. Oxymetazoline Hydrochloride Nasal Drops are indicated for the treatment of acute and chronic rhinitis, sinusitis and allergic rhinitis. Taurine Eye Drops are approved for the treatment of acute and chronic conjunctivitis. Both rhinitis and conjunctivitis are common in China, especially in colder regions. More details...

Stock Symbols: (OTCBB: CSKI)